Blog

In Dr. Sabrina Ronen’s lab, researchers are focusing on developing new, non-invasive imaging biomarker indicators to address multiple types of cancers–from breast cancer, prostate cancer and higher-grade aggressive glioblastoma brain tumors to lower-grade, somewhat less aggressive tumors of the brain.

At last month’s Department of Radiology and Biomedical Imaging’s Annual Research Symposium, Caroline Guglielmetti, PhD, was awarded the 2017 Hasegawa Award. The annual Hasegawa Award recognizes a graduate student or postdoctoral scholar exemplifying the scope and quality of investigation demonstrated by Dr. Bruce Hasegawa during his career.

In this video, Dr. Vigneron describes his work and how it’s helping tens of thousands of patients with prostate cancer and brain tumors by more accurately identifying the location of cancers, monitoring whether those cancers are responding to treatment, and, as needed, adjusting the treatment to more specifically target the disease.

The UCSF Research Interest Groups (RIGs) are a success story for many reasons. In this post, hear from Dr. Vigneron and other members of the Research Interest Group to understand what makes RIGs work:

Uterine fibroids are the most common benign tumors of the female pelvis. High-intensity focused ultrasound (or HIFU) is a relatively novel FDA-approved noninvasive outpatient treatment option available for women with symptomatic fibroids

William Dillon, MD, has agreed to serve as interim chair of the Department of Radiology and Biomedical Imaging, effective October 1, 2017, following the retirement of long-time chair Ron Arenson, MD. The search for a permanent new chair is ongoing, and we hope to be able to make an announcement before the end of the year.

Pages